Injury
Volume 40, Issue 12 , Pages 1243-1244 , December 2009

Fracture healing and bone regeneration: Autologous bone grafting or BMPs?

References 

  1. Axelrad TW, Kakar S, Einhorn TA. New technologies for the enhancement of skeletal repair. Injury. 2007;38(Suppl. 1):S49–S62
  2. Biddulph SL. Bone donor site. Iliac crest or distal radius?. J Hand Surg [Br]. 1999;24(6):645–646
  3. Blokhuis TJ, Lindner T. Allograft and bone morphogenetic proteins: an overview. Injury. 2008;39(Suppl. 2):S33–S36
  4. Bruno RJ, Cohen MS, Berzins A, Sumner DR. Bone graft harvesting from the distal radius, olecranon, and iliac crest: a quantitative analysis. J Hand Surg [Am]. 2001;26(1):135–141
  5. Calori GM, Tagliabue L, Gala L, et al. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients. Injury. 2008;39(December (12)):1391–1402
  6. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004;22:233–241
  7. Crowley DJ, Kanakaris NK, Giannoudis PV. Femoral diaphyseal aseptic non-unions: is there an ideal method of treatment?. Injury. 2007;38(May (Suppl. 2)):S55–S63
  8. Dimitriou R, Dahabreh Z, Katsoulis E, et al. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury, Int J Care Injured. 2005;(36S):S51–S59
  9. Donati D, Di Bella C, Lucarelli E, et al. OP-1 application in bone allograft integration: preliminary results in sheep experimental surgery. Injury. 2008;39(Suppl. 2):S65–S72
  10. Drosse I, Volkmer E, Capanna R, et al. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury. 2008;Suppl. 2(39):S9–S20
  11. Einhorn TA. Clinical applications of recombinant human BMPs: early experience and future development. J Bone Joint Surg Am. 2003;85(Suppl. 3):82–88
  12. Ekrol I, Hajducka C, Court-Brown C, McQueen MM. A comparison of RhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius. Injury. 2008;39(Suppl. 2):S73–S82
  13. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogeneticProtein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83(Suppl. 1):S151–S158
  14. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36(Suppl. 3):S20–S27
  15. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury. 2007;38(September (Suppl. 4)):S3–S6
  16. Giannoudis PV, Einhorn TA, Schmidmaier G, Marsh D. The diamond concept—open questions. Injury. 2008;39(September (Suppl. 2)):S5–S8
  17. Giannoudis PV, Kanakaris NK, Dimitriou R, et al. The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions. Clin Orthop Relat Res. 2009;(April):
  18. Giannoudis PV, Psarakis S, Kanakaris NK, Pape HC. Biological enhancement of bone healing with Bone Morphogenetic Protein-7 at the clinical setting of pelvic girdle non-unions. Injury. 2007;38(September (Suppl. 4)):S43–S48
  19. Giannoudis P, Tzioupis C, Almalki T, Buckley R. Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury. 2007;38(March (Suppl. 1)):S90–S99
  20. Giannoudis PV, Tzioupis C. Clinical applications of BMP-7. The UK perspective. Injury, Int J Care Injured. 2005;36S:S47–S50
  21. Greenwald AS, Boden SD, Goldberg VM, et al. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am. 2001;83-A(Suppl. 2 Pt 2):98–103
  22. Goulet JA, Senunas LE, DeSilva GL, Greenfield ML. Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res. 1997;339:76–81
  23. Govender S, Csimma C, Genant HK, et al. BMP-2 evaluation in surgery for tibial trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84:2123–2134
  24. Johnson EE, Urist MR. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop Relat Res. 2000;371:61–74
  25. Ilankovan V, Stronczek M, Telfer M, et al. A prospective study of trephined bone grafts of the tibial shaft and iliac crest. Br J Oral Maxillofac Surg. 1998;36(6):434–439
  26. Kanakaris NK, Calori GM, Verdonk R, et al. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury. 2008;39(September (Suppl. 2)):S83–S90
  27. Kanakaris NK, Paliobeis C, Manidakis N, Giannoudis PV. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury. 2007;38(May (Suppl. 2)):S65–S75
  28. Khan SN, Cammisa FP, Sandhu HS, et al. The biology of bone grafting. J Am Acad Orthop Surg. 2005;13:77–86
  29. Keramaris NC, Calori GM, Nikolaou VS, et al. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury. 2008;39(September (Suppl. 2)):S45–S57
  30. Laurencin CT, Einhorn TA, Lyons K. Fracture repair: challenges and opportunities. J Bone Joint Surg Am. 2008;90(February (Suppl. 1)):1–2
  31. Leung PC. Current trends in bone grafting. Berlin: Springer-Verlag; 1989;
  32. Mahendra A, Maclean AD. Available biological treatments for complex non-unions. Injury. 2007;38(Suppl. 4):S7–S12
  33. Matthews SJ. Biological activity of bone morphogenetic proteins (BMP's). Injury. 2005;36(Suppl. 3):S34–S37
  34. Matthews SJ, Nikolaou VS, Giannoudis PV. Innovations in osteosynthesis and fracture care. Injury. 2008;39(August (8)):827–838
  35. Morgan EF, Mason ZD, Bishop G, et al. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1–34) in metaphyseal bone healing. Bone. 2008;43(December (6)):1031–1038
  36. Papathanasopoulos A, Giannoudis PV. Biological considerations of mesenchymal stem cells and endothelial progenitor cells. Injury. 2008;39(September (Suppl. 2)):S21–S32
  37. Pountos I, Corscadden D, Emery P, Giannoudis PV. Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury. 2007;38(September (Suppl. 4)):S23–S33
  38. Schmidmaier G, Schwabe P, Wildemann B, Haas NP. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury. 2007;38(Suppl. 4):S35–S41
  39. Schnitzler CM, Biddulph SL, Mesquita JM, Gear KA. Bone structure and turnover in the distal radius and iliac crest: a histomorphometric study. J Bone Miner Res. 1996;11(11):1761–1768
  40. Stylios G, Wan T, Giannoudis P. Present status and future potential of enhancing bone healing using nanotechnology. Injury. 2007;38(March (Suppl. 1)):S63–S74
  41. Termaat MF, Den Boer FC, Bakker FC, et al. Bone morphogenetic proteins development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am. 2005;87:1367–1378
  42. Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: Which are the important molecules?. Injury. 2007;38(Suppl. 1):S11–S25
  43. Tzioupis C, Giannoudis PV. Prevalence of long-bone non-unions. Injury. 2007;38(May (Suppl. 2)):S3–S9
  44. Uludag H, Gao T, Porter TJ, et al. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am. 2001;83(Suppl. 1 Pt 2):S128–S135
  45. Vaibhav B, Nilesh P, Vikram S, Anshul C. Bone morphogenic protein and its application in trauma cases: a current concept update. Injury. 2007;38:1227–1235
  46. Veillette CJ, McKee MD. Growth factors—BMPs, DBMs, and buffy coat products: are there any proven differences amongst them?. Injury. 2007;38(Suppl. 1):S38–S48
  47. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242(4885):1528–1534

PII: S0020-1383(09)00526-9

doi: 10.1016/j.injury.2009.10.004

Injury
Volume 40, Issue 12 , Pages 1243-1244 , December 2009

Article Tools